Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
skin irritation: in vitro / ex vivo
Type of information:
experimental study
Adequacy of study:
key study
Study period:
27 February 2020 to 14 April 2020
Reliability:
1 (reliable without restriction)

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2020
Report date:
2020

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
Version / remarks:
(2019)
GLP compliance:
yes (incl. QA statement)

Test material

Constituent 1
Chemical structure
Reference substance name:
4-Methyl-N-[[[3-(trifluoromethyl)phenyl]amino]carbonyl] benzenesulfonamide
EC Number:
850-929-8
Cas Number:
1584-79-8
Molecular formula:
C15H13F3N2O3S
IUPAC Name:
4-Methyl-N-[[[3-(trifluoromethyl)phenyl]amino]carbonyl] benzenesulfonamide
Test material form:
solid

In vitro test system

Test system:
human skin model
Source species:
human
Cell type:
non-transformed keratinocytes
Cell source:
other: The EPSKIN TM model is a three dimensional reconstructed human epidermis model consisting of adult human derived epdermal keratinocytes
Vehicle:
unchanged (no vehicle)
Details on test system:
EpiDermTm SIT kit:
Manufacturer MatTek Corporation
receipt date: 2 March 2020
Components: EpiDerm tissue (Lot Number 32183), assay medium (Lot Number: 022620TVKD), Nylon mesh (Lot Number: 0551428-00), Phosphate buffered saline without Ca2+ and MG2+, 5% SDS solution
The tissue insert and the medium were stored in a cold place. Nylon mesh and phosphate buffered saline without Ca2+ and Mg2+ were stored at room temperature.
Control samples:
yes, concurrent negative control
yes, concurrent positive control
Amount/concentration applied:
25 mg test substance or 30µL of the control substances respectively per tissue
Duration of treatment / exposure:
Incubation of all plates for 35 +/- 1 minute and until 60 minutes at room temperature afterwards.
Duration of post-treatment incubation (if applicable):
42 hours
Number of replicates:
3 per control group (Test substance, negative control and positive control)

Results and discussion

In vitro

Resultsopen allclose all
Irritation / corrosion parameter:
% tissue viability
Run / experiment:
positive control
Value:
2.2
Vehicle controls validity:
not applicable
Negative controls validity:
valid
Positive controls validity:
valid
Irritation / corrosion parameter:
% tissue viability
Run / experiment:
Mean Negative Control
Value:
100
Vehicle controls validity:
not applicable
Negative controls validity:
valid
Positive controls validity:
valid
Irritation / corrosion parameter:
% tissue viability
Run / experiment:
Mean test item
Value:
100
Vehicle controls validity:
not applicable
Negative controls validity:
valid
Positive controls validity:
valid

Any other information on results incl. tables

Acceptable criteria of the test were met:


Mean OD in the negative control substance group is >= 0.8 and =< 2.8


Mean cell viability in the positive control substance group is <10%


SDs of cell viablities in each treatment group used three tissue inserts are 0< 18%.


 


In a preliminary test it was confirmed that the test item has no reactivity with MTT. Therefore the interference of the test substance with MTT was not evaluated in the skin irritation test.


As a result of tissue-binding test, the staining ratio was 02% whic is く 5%. Therefore, correction of OD was not conducted.
The mean OD in the negative control was l.809. The mean cell viability in the
 positive control substance was 2.2%. The SDs of cell viabilities in the negative and the positive control substances, and the test substances were 4.9% , 0.1% and 3.4 %, respectively. These results indicated thatt the present study was appropriately performed. As a result of skin irritation test, the cell viability treated by the test item was 100.0%, exceeding 50%, which is the judgement criteria of skin irritation.


 

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
It was concluded that the test item was "Non-irritant" (UN GHS Category: not classified (including UN GHS Category 3).
Executive summary:

The ability of the test item to induce skin irritation was investigated using EpiDermTM SIT (EPI-200). As a result of the skin irritation test, the cell viability treated with the test item was 100.0% exceeding 50% which is the judgement criteria of skin irritation. Consequently, it was concluded that the test item was "Non-irritant" (UN GHS Category: not classified (including UN GHS Category 3).